Interactions between promazine and antidepressants at the level of celllular distribution

Pharmacology and Toxicology

Volumn 81, Issue 6, 1997, Pages 259-264

  Daniel, Władyslawa Anna ^a   Wójcikowski, Jacek ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; FLUOXETINE; IMIPRAMINE; PROMAZINE; SERTRALINE;

ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG INTERACTION; LYSOSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE SLICE;

1-NAPHTHYLAMINE; AMITRIPTYLINE; AMMONIUM CHLORIDE; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CARBAMAZEPINE; DRUG INTERACTIONS; FLUOXETINE; HYDROGEN-ION CONCENTRATION; IMIPRAMINE; LYSOSOMES; MALE; PROMAZINE; RATS; RATS, WISTAR; SERTRALINE;

ANIMALIA;

EID: 0030772327     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Besret, L., D. Debruyne, P. Rioux, T. Bonvalot, M. Moulin, E. Zarifian & J.-C. Baron: A comprehensive investigation of plasma and brain regional pharmacokinetics of imipramine and its metabolites during and after chronic administration in the rat. J. Pharm. Sci. 1996, 85, 291-295.
2. Bickel, M. H.: Factors affecting the storage of drugs and other xenobiotics in adipose tissue. Adv. Drug Res. 1994, 25, 55-86.
3. Bickel, M. H. & J. W. Steele: Binding of basic and acidic drugs to rat tissue subcellular fractions. Chem. Biol. Interactions 1974, 25, 55-86.
4. Daniel, W. A., M. H. Bickel & U. E. Honegger: The contribution of lysosomal trapping in the uptake of desipramine and chloroquine by different tissues. Pharmacology Toxicology 1995, 77, 402-406.
5. 3H] desipramine binding sites in the rat brain after acute and chronic treatment with imipramine. J. Pharm. Pharmacol. 1991, 43, 31-35.
6. Daniel, W. & M. Melzacka: The effect of neuroleptics on imipramine demethylation in rat liver microsomes and imipramine and desipramine level in the rat brain. Biochem. Pharmacol. 1986, 35, 3249-3253.
7. Daniel, W. A. & J. Wojcikowski: Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs. Pharmacology Toxicology 1997, 80, 62-68.
8. de Duve, C., T. Barsy, B. Poole, A. Trouet, P. Tulkens & F. van Hoof: Lysosomotropic agents. Biochem. Pharmacol. 1974, 23, 2495-2531.
9. Di Francesco, C. & M. H. Bickel: Membrane lipids as intracellular binders of chloropromazine and related drugs. Chem. Biol. Interactions 1977, 16, 335-346.
10. Honegger, U. E., A. A. Roscher & U. N. Wiesmann: Evidence for lysosomotropic action of desipramine in cultured human fibroblast. J. Pharmacol. Exp. Therap. 1983, 225, 436-441.
11. Kornhuber, J., W. Retz & P. Riederer: Slow accumulation of psychotropic drugs in the human brain. Relationship to therapeutic latency of neuroleptic and antidepressant drugs. J. Neural Transm. 1995, 46, 315-323.
12. Lüllmann, H. & M. Wehling: The binding of drugs to different polar lipids in vitro. Biochcm. Pharmacol. 1979, 28, 3409-3415.
13. MacIntyre, A. & D. J. Cutler: Role of lysosomes in hepatic accumulation of chloroquine. J. Pharm. Sci. 1988a. 77, 196-199.
14. MacIntyre, A. & D. J. Cutler: The potential role of lysosomes in tissue distribution of weak bases. Biopharm. Drug Disp. 1988b, 9, 513-526.
15. Moor, M., U. E. Honegger & U. N. Wiesmann: Organspecific, qualitative changes in the phospholipid composition of rats after chronic administration of the antidepressant drug desipramine. Biochem. Pharmacol. 1988, 37, 2035-2039.
16. Murthy, K. S. & G. Zografi: Oil-water partitioning of chlorpromazine and other phenothiazine derivatives using dodecane and n-octanol. J. Pharm. Sci. 1970, 59, 1281-1285.
17. Novelli, A., P. G. Lysko & R. C. Henneberry: Uptake of imipramine in neurons cultured from rat cerebellum. Brain Res. 1987, 411, 291-297.
18. Ohkuma, S. & B. Poole: Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA 1978, 75, 3327-3331.
19. Parker G., K. Roy, D. Hadzi-Pavlovic & F. Pedic: Psychotic (delusional) depression: a meta-analysis of physical treatments. J. Affect. Disord. 1992, 24, 17-24.
20. Römer, J. & M. H. Bickel: Interactions of chloropromazine and imipramine with artificial membranes investigated by equilibrium dialysis, dual-wavelength photometry, and fluorimetry. Biochem. Pharmacol. 1979, 28, 799-805.
21. Toplak, H., R. Zuelke, S. Loidl, A. Hermetter, U. E. Honegger & U. N. Wiesmann: Single and multiple desipramine exposures of cultured cells. Biochem. Pharmacol. 1990, 39, 1437-1443.
22. Vandel, B., S. Vandel, G. Allers, P. Bechtel and R. Volmat: Interaction between amitriptyline and phenothiazine in man: Effect on plasma concentration of amitriptyline and its metabolites nortriptyline and the correlation with clinical response. Psychopharmacology 1979, 65, 187-190.
23. Vandel, B., G. Bertschy, P. Baumann, S. Bouquet, B. Bonin, T. Francois, D. Sechter & P. Bizouard: Fluvoxamine and fluoxetine: Interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients. Pharmacol. Res. 1995, 31, 347-353.
24. Vestal, R. E., D. M. Kornhauser & D. G. Shand: Active uptake of propranolol by isolated rabbit alveolar macrophages and its inhibition by other basic amines. J. Pharmacol. Exp. Therap. 1980, 214, 106-111.